New chief executive and chairman for Evaluate
pharmafile | September 9, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | alex karle, evaluate
Life science market intelligence firm Evaluate has appointed Alex Karle to the role of chief executive, replacing the firm’s founder Dr Jonathan de Pass in the role who is now its chairman.
As chief operating officer Karle (pictured) had been responsible for sales, marketing and business development for Evaluate, and the creation of new products and software capabilities.
Prior to his role at Evaluate, he served as a VP of strategy and development of IP and science at Thomson Reuters. Karle began his career as a senior associate at Booz Allen & Hamilton.
“It’s been an absolute privilege and a joy working with so many talented colleagues and clients over the years” says de Pass. “It’s now time to hand the reins over to Alex. Under his leadership and supported by a first class team, I’m confident that Evaluate is in excellent hands and will continue to develop its services to provide ever more benefits for our clients. I congratulate Alex on his appointment.”
Karle adds: “With his drive and vision, Jonathan has created a world leading organisation and he has set a very high standard. I am very much looking forward to taking on the CEO position.”






